PRODUCTS
APIs and intermediates
No data

No data

  • Temozolomide
  • Temozolomide
  • Temozolomide
  • Temozolomide
  • Temozolomide
Temozolomide
Temozolomide
Temozolomide
Temozolomide
Temozolomide
+

Share

Temozolomide



Summary:

Temozolomide is the first oral effective imidazo tetrazine antitumor drug. It belongs to the second generation alkylating agent with antitumor activity.

CAS:

85622-93-1

Standard:

USP/BP

Purity:


Keywords:

API and Intermediates

  • Product description
  • Product Intro

    Temozolomide is the first oral effective imidazo tetrazine antitumor drug. It belongs to the second generation alkylating agent with antitumor activity. It does not need intrahepatic metabolic activation after oral administration. It is characterized by easy penetration through the blood-brain barrier, good tolerance and no superimposed toxicity with other drugs. It has synergistic effect with radiotherapy. It is suitable for malignant gliomas that relapse after routine treatment, For example, glioblastoma multiforme or degenerative astrocytoma is also the first-line drug for the treatment of metastatic melanoma.


    Function

    It can degrade spontaneously and quickly in vivo to produce the active metabolite mtic and produce antitumor effect. Uses: used as antitumor drugs.
    Application

    This product is suitable for the treatment of adult patients with intractable pleomorphic glioblastoma.

Previous page

Next page

Previous page

Next page

Messages

Note: Please provide accurate and detailed information, and our professional staff will contact you as soon as possible!

Recommended products